Vaarala MH - Search Results

1

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S; PRACTICAL Consortium; Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH. Gao P, et al. Among authors: vaarala mh. Cell. 2018 Jul 26;174(3):576-589.e18. doi: 10.1016/j.cell.2018.06.003. Epub 2018 Jul 19. Cell. 2018. PMID: 30033361 Free PMC article.

2

The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.

Vaarala MH, Mattila H, Ohtonen P, Tammela TL, Paavonen TK, Schleutker J. Vaarala MH, et al. Int J Cancer. 2008 Jun 1;122(11):2511-6. doi: 10.1002/ijc.23425. Int J Cancer. 2008. PMID: 18306354

3

Sacral neuromodulation in urological indications: the Finnish experience.

Vaarala MH, Tammela TL, Perttilä I, Luukkonen P, Hellström P. Vaarala MH, et al. Scand J Urol Nephrol. 2011 Feb;45(1):46-51. doi: 10.3109/00365599.2010.523013. Epub 2010 Oct 21. Scand J Urol Nephrol. 2011. PMID: 20961268

4

[The effect of castration on bone in prostate cancer patients].

Vaarala M, Kähkönen E, Viitanen J, Taari K, Tammela T. Vaarala M, et al. Duodecim. 2011;127(11):1129-36. Duodecim. 2011. PMID: 21755804 Review. Finnish.

5

A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.

Huang Q, Whitington T, Gao P, Lindberg JF, Yang Y, Sun J, Väisänen MR, Szulkin R, Annala M, Yan J, Egevad LA, Zhang K, Lin R, Jolma A, Nykter M, Manninen A, Wiklund F, Vaarala MH, Visakorpi T, Xu J, Taipale J, Wei GH. Huang Q, et al. Among authors: vaarala mh. Nat Genet. 2014 Feb;46(2):126-35. doi: 10.1038/ng.2862. Epub 2014 Jan 5. Nat Genet. 2014. PMID: 24390282

6

Disassembly of α6β4-mediated hemidesmosomal adhesions promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin to focal adhesions.

Wenta T, Schmidt A, Zhang Q, Devarajan R, Singh P, Yang X, Ahtikoski A, Vaarala M, Wei GH, Manninen A. Wenta T, et al. Oncogene. 2022 Jul;41(30):3804-3820. doi: 10.1038/s41388-022-02389-5. Epub 2022 Jul 1. Oncogene. 2022. PMID: 35773413 Free PMC article.

7

Dampened Regulatory Circuitry of TEAD1/ITGA1/ITGA2 Promotes TGFβ1 Signaling to Orchestrate Prostate Cancer Progression.

Cruz SP, Zhang Q, Devarajan R, Paia C, Luo B, Zhang K, Koivusalo S, Qin L, Xia J, Ahtikoski A, Vaarala M, Wenta T, Wei GH, Manninen A. Cruz SP, et al. Adv Sci (Weinh). 2024 Mar;11(11):e2305547. doi: 10.1002/advs.202305547. Epub 2024 Jan 2. Adv Sci (Weinh). 2024. PMID: 38169150 Free PMC article.

8

Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression.

Vaarala MH, Porvari K, Kyllönen A, Vihko P. Vaarala MH, et al. Lab Invest. 2000 Aug;80(8):1259-68. doi: 10.1038/labinvest.3780134. Lab Invest. 2000. PMID: 10950117 Free article.

9

The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease.

Vaarala MH, Porvari K, Kyllönen A, Lukkarinen O, Vihko P. Vaarala MH, et al. Int J Cancer. 2001 Dec 1;94(5):705-10. doi: 10.1002/ijc.1526. Int J Cancer. 2001. PMID: 11745466

10

Characterization of androgen-regulated expression of CYP3A5 in human prostate.

Moilanen AM, Hakkola J, Vaarala MH, Kauppila S, Hirvikoski P, Vuoristo JT, Edwards RJ, Paavonen TK. Moilanen AM, et al. Among authors: vaarala mh. Carcinogenesis. 2007 May;28(5):916-21. doi: 10.1093/carcin/bgl222. Epub 2006 Nov 20. Carcinogenesis. 2007. PMID: 17116727

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters